Of note, human genomic databases (TCGA, METABRIC etc.)show a high degree of p53 LOH in all examined tumor types that carry missense p53 mutations, including sarcomas and breast carcinomas (with and without HER2 amplification). Here, ERBB2 is linked to neoplasm.